It improves insulin resistance and hepatic steatosis by attenuating α-2-HS-glycoprotein (AHSG), suggesting its involvement in the pathogenetic mechanisms of diabetes and NAFLD (Heo et al., 2018). Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.